Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Combination prevention: a deeper understanding of effective HIV prevention.

Hankins CA, de Zalduondo BO.

AIDS. 2010 Oct;24 Suppl 4:S70-80. doi: 10.1097/01.aids.0000390709.04255.fd.

PMID:
21042055
2.

Male circumcision for HIV prevention: current research and programmatic issues.

Weiss HA, Dickson KE, Agot K, Hankins CA.

AIDS. 2010 Oct;24 Suppl 4:S61-9. doi: 10.1097/01.aids.0000390708.66136.f4.

3.

HIV vaccines: current status worldwide and in Africa.

Fast PE, Kaleebu P.

AIDS. 2010 Oct;24 Suppl 4:S50-60. doi: 10.1097/01.aids.0000390707.58512.5e.

PMID:
21042053
4.

The last decade of microbicide clinical trials in Africa: from hypothesis to facts.

Ramjee G, Kamali A, McCormack S.

AIDS. 2010 Oct;24 Suppl 4:S40-9. doi: 10.1097/01.aids.0000390706.81383.f3.

PMID:
21042052
5.

Behavioural interventions to reduce HIV risk: what works?

Ross DA.

AIDS. 2010 Oct;24 Suppl 4:S4-14. doi: 10.1097/01.aids.0000390703.35642.89.

PMID:
21042051
6.
7.

Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?

Hayes R, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit J.

AIDS. 2010 Oct;24 Suppl 4:S15-26. doi: 10.1097/01.aids.0000390704.35642.47.

8.

A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.

Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, Lees S, Stadler J, Crook A, Nunn A, Hayes R, McCormack S.

PLoS One. 2010 Jul 21;5(7):e11600. doi: 10.1371/journal.pone.0011600.

9.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group.

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

10.

Effect of treating co-infections on HIV-1 viral load: a systematic review.

Modjarrad K, Vermund SH.

Lancet Infect Dis. 2010 Jul;10(7):455-63. doi: 10.1016/S1473-3099(10)70093-1. Review.

11.

Weighing the gold in the gold standard: challenges in HIV prevention research.

Padian NS, McCoy SI, Balkus JE, Wasserheit JN.

AIDS. 2010 Mar 13;24(5):621-35. doi: 10.1097/QAD.0b013e328337798a. Review.

12.

Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis.

Hilber AM, Francis SC, Chersich M, Scott P, Redmond S, Bender N, Miotti P, Temmerman M, Low N.

PLoS One. 2010 Feb 9;5(2):e9119. doi: 10.1371/journal.pone.0009119. Review.

13.

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.

Dodd PJ, Garnett GP, Hallett TB.

AIDS. 2010 Mar 13;24(5):729-35. doi: 10.1097/QAD.0b013e32833433fe.

14.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators.

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

15.

HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda.

Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH.

AIDS. 2009 Nov 27;23(18):2479-84. doi: 10.1097/QAD.0b013e328330cc08.

16.

Alternatives to randomisation in the evaluation of public health interventions: design challenges and solutions.

Bonell CP, Hargreaves J, Cousens S, Ross D, Hayes R, Petticrew M, Kirkwood BR.

J Epidemiol Community Health. 2011 Jul;65(7):582-7. doi: 10.1136/jech.2008.082602. Epub 2009 Feb 12. Review.

PMID:
19213758
17.

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG.

Lancet. 2009 Jan 3;373(9657):48-57. doi: 10.1016/S0140-6736(08)61697-9. Epub 2008 Nov 27.

PMID:
19038438
18.

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ.

Lancet. 2007 Feb 24;369(9562):657-66.

PMID:
17321311
19.

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO.

Lancet. 2007 Feb 24;369(9562):643-56.

PMID:
17321310
20.

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A.

PLoS Med. 2005 Nov;2(11):e298. Epub 2005 Oct 25. Erratum in: PLoS Med. 2006 May;3(5):e298.

Supplemental Content

Support Center